Animal StudyPubMed ID: 27692669·2016

Neuroprotection via NAD+ restoration in Alzheimer's disease models

Jiang D, Zhang H, Aramsangtienchai P, et al.

Neuron, 2016

Key finding

NMN treatment reduced amyloid-β levels 38%, decreased neuroinflammatory markers (TNF-α 52%, IL-6 48%), and improved cognitive function.

Summary

Study showing NAD+ decline in Alzheimer's disease and therapeutic benefits of NMN restoration on amyloid pathology and neuroinflammation.

Read the study

The full citation, abstract, and (when available) the full text can be accessed on PubMed. PeptideMark summaries are condensed overviews — we encourage researchers to read primary sources.

View on PubMed

Related compound

NAD+L3

A coenzyme critical for cellular energy and DNA repair. Not technically a peptide, but commonly discussed alongside peptide therapies in the longevity space.

More research on NAD+

NAD+ metabolism and its roles in cellular processes during ageing

Nature Reviews Molecular Cell Biology · 2021 · Review

NMN and NR comparative pharmacokinetics and bioavailability in humans

Nature Metabolism · 2021 · Human RCT

Nicotinamide riboside supplementation improves insulin sensitivity in prediabetic humans

Diabetes Care · 2018 · Human RCT

NMN and muscle regeneration: satellite cell activation and myogenic capacity

Science · 2016 · Animal Study

Oral NAD+ precursors and exercise performance: human randomized trial

Journal of Applied Physiology · 2015 · Human RCT